Why ICU Medical, Inc.’s (ICUI) Stock Is Up 12.16%

By Cynthia McLaughlin
August 10, 2026
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate ICU Medical, Inc. before investing.

In this article, we go over a few key elements for understanding ICU Medical, Inc.’s stock price such as:

  • ICU Medical, Inc.’s current stock price and volume
  • Why ICU Medical, Inc.’s stock price changed recently
  • Upgrades and downgrades for ICUI from analysts
  • ICUI’s stock price momentum as measured by its relative strength

About ICU Medical, Inc. (ICUI)

Before we jump into ICU Medical, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company’s customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Want to learn more about ICU Medical, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about ICU Medical, Inc..

Learn More About A+ Investor

ICU Medical, Inc.’s Stock Price as of Market Close

As of August 10, 2026, 4:00 PM, CST, ICU Medical, Inc.’s stock price was $182.420.

ICU Medical, Inc. is down 1.16% from its previous closing price of $184.560.

During the last market session, ICU Medical, Inc.’s stock traded between $180.885 and $186.170. Currently, there are approximately 25.00 million shares outstanding for ICU Medical, Inc..

ICU Medical, Inc.’s price-earnings (P/E) ratio is currently at 153.3, which is high compared to the Health Care Equipment & Supplies industry median of 29.9. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

ICU Medical, Inc. Stock Price History

ICU Medical, Inc.’s (ICUI) price is currently up 8.25% so far this month.

During the month of August, ICU Medical, Inc.’s stock price has reached a high of $192.850 and a low of $164.090.

Over the last year, ICU Medical, Inc. has hit prices as high as $192.850 and as low as $107.000. Year to date, ICU Medical, Inc.’s stock is up 27.86%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused ICU Medical, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 07, 2026, there were 0 analysts who downgraded ICU Medical, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate ICU Medical, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on ICU Medical, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

ICU Medical, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about ICU Medical, Inc. (ICUI) by visiting AAII Stock Evaluator.

Relative Price Strength of ICU Medical, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 07, 2026, ICU Medical, Inc. has a weighted four-quarter relative price strength of 13.12%, which translates to a Momentum Score of 86 and is considered to be Very Strong.

Want to learn more about how ICU Medical, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

ICU Medical, Inc. Stock Price: Bottom Line

As of August 10, 2026, ICU Medical, Inc.’s stock price is $182.420, which is down 1.16% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like ICU Medical, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
Zweig Screen: 11.3% Compared to S&P 500
at only 6.9%

Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.